Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting...
16 insider purchases on record · latest filing 2023-03-02.
Insiders have also filed 428 sale transactions at VIR.